More importantly, we found that although none of the genes on the list were associated with patient survival in the TAZ-AXL-CTGF-high group of patients (data not shown), MGP, PDLIM3, TAGLN and ZEB2 were predictors of survival in the TAZ-AXL-CTGF-low group of patients, in the combined colon cancer patient cohort (Figure 5). This evidence concerns the gene MGP and malignant colon neoplasm.